Adirondack Trust CO Eli Lilly & CO Transaction History

Adirondack Trust CO

$259 Million
Q3 2024

A detailed history of Adirondack Trust CO transactions in Eli Lilly & CO stock. As of the latest transaction made, Adirondack Trust CO holds 4,682 shares of LLY stock, worth $3.59 Million. This represents 1.6% of its overall portfolio holdings.

Number of Shares

4,682

Previous 4,587 2.07%

Holding current value

$3.59 Million

Previous $4.15 Million 0.12%

% of portfolio

1.6%

Previous 1.7%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$772.14 - $960.02 $73,353 - $91,201	95 Added 2.07%	4,682 $4.15 Million
Q2 2024 Jul 09, 2024	SELL	$724.87 - $909.04 $32,619 - $40,906	-45 Reduced 0.97%	4,587 $4.15 Million
Q1 2024 Apr 09, 2024	SELL	$592.2 - $792.28 $15,397 - $20,599	-26 Reduced 0.56%	4,632 $3.6 Million
Q4 2023 Mar 29, 2024	SELL	$525.19 - $619.13 $29,410 - $34,671	-56 Reduced 1.19%	4,658 $2.72 Million
Q3 2023 Oct 31, 2023	SELL	$434.7 - $599.3 $33,471 - $46,146	-77 Reduced 1.61%	4,714 $2.53 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $102,065 - $136,473	-291 Reduced 5.73%	4,791 $2.25 Million
Q1 2023 Apr 28, 2023	SELL	$310.63 - $364.82 $3,727 - $4,377	-12 Reduced 0.24%	5,082 $1.75 Million
Q4 2022 Jan 13, 2023	BUY	$321.55 - $374.67 $1,286 - $1,498	4 Added 0.08%	5,094 $0
Q3 2022 Oct 13, 2022	BUY	$296.48 - $337.87 $68,783 - $78,385	232 Added 4.78%	5,090 $1.65 Million
Q2 2022 Jul 06, 2022	BUY	$278.73 - $327.27 $36,513 - $42,872	131 Added 2.77%	4,858 $1.58 Million
Q1 2022 Apr 05, 2022	BUY	$234.69 - $291.66 $92,467 - $114,914	394 Added 9.09%	4,727 $1.35 Million
Q4 2021 Jan 13, 2022	SELL	$224.85 - $279.04 $268,021 - $332,615	-1,192 Reduced 21.57%	4,333 $1.2 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $30,359 - $37,361	-137 Reduced 2.42%	5,525 $1.41 Million
Q2 2021 Jul 15, 2021	SELL	$180.55 - $233.54 $22,568 - $29,192	-125 Reduced 2.16%	5,662 $1.3 Million
Q1 2021 Apr 16, 2021	BUY	$164.32 - $212.72 $70,657 - $91,469	430 Added 8.03%	5,787 $1.08 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $25,439 - $33,662	-195 Reduced 3.51%	5,357 $1.11 Million
Q2 2020 Aug 19, 2020	SELL	$136.42 - $164.18 $12,959 - $15,597	-95 Reduced 1.68%	5,552 $834,000
Q1 2020 Apr 23, 2020	SELL	$119.05 - $147.35 $17,857 - $22,102	-150 Reduced 2.59%	5,647 $783,000
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $53,460 - $66,215	-500 Reduced 7.94%	5,797 $809,000
Q2 2019 Jul 15, 2019	SELL	$110.79 - $129.32 $3,323 - $3,879	-30 Reduced 0.47%	6,297 $698,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $29,719 - $34,982	-267 Reduced 4.05%	6,327 $741,000
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $25,416 - $28,473	-240 Reduced 3.51%	6,594 $763,000
Q3 2018 Oct 22, 2018	SELL	$85.86 - $107.31 $7,298 - $9,121	-85 Reduced 1.23%	6,834 $734,000
Q1 2018 May 03, 2018	SELL	$74.21 - $87.6 $76,287 - $90,052	-1,028 Reduced 12.94%	6,919 $561,000
Q4 2017 Jan 10, 2018	SELL	$81.94 - $87.89 $44,247 - $47,460	-540 Reduced 6.36%	7,947 $671,000
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $654,093 - $725,977	8,487	8,487 $726,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adirondack Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Adirondack Trust CO with notifications on news.

Account

Adirondack Trust CO Eli Lilly & CO Transaction History